Borak Capital Holding S.A.E. Engages BGR Capital & Trade, LLC As Exclusive Financial Advisor

By Bgr Capital Trade Llc, PRNE
Tuesday, November 17, 2009

NEW YORK, November 18 - Borak Capital Holding S.A.E. ("Borak") announced today the signing of an
agreement with BGR Capital & Trade, LLC ("BGR C&T") whereby BGR C&T has
agreed to act as the exclusive financial advisor to Borak.

Dr. Ayman Kandeel, Chairman of Borak commented, "We are excited about our
new partnership with BGR C&T and look forward to working with them as we
continue to grow our company. We believe that our development opportunities
on the Nile and on the Mediterranean Coast of Egypt are unique opportunities
to participate in the continued development of Egypt, and to showcase its
history and beauty for generations to come."

Mr. Ken Griffin, President of BGR C&T said, "The combination of BGR C&T's
experience in Egypt, unique relationships and advisory capabilities with the
strength of Borak's management team and local opportunities present a very
exciting opportunity. Not only will the Borak real estate developments be
compelling business opportunities but will also have significant impact on
the region."

About Borak Capital Holding S.A.E.

Borak is a real estate development company headquartered in Cairo, Egypt.
Borak has established a strategic alliance with MGM, as well as with other
regional partners, as it plans to develop two luxury hotels on the Nile river
in Cairo in addition to developing its extensive land holdings on the
Mediterranean Coast of Egypt.

About BGR Capital & Trade, LLC

BGR Capital & Trade, LLC (BGR C&T) provides expert investment banking
services while leveraging the global base of relationships and expertise that
comes with the BGR brand. BGR C&T President Ken Griffin has prior experience
working in the Egyptian market. In 2006, Griffin served as Managing Director
for the investment banking team representing the key shareholders in the
divestiture of their interests in Amoun Pharmaceuticals, Egypt's domestic
leader in the production of pharmaceutical products.

Robert Rinaldi of BGR Capital & Trade, rrinaldi at

will not be displayed